期刊
THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE
卷 11, 期 8, 页码 215-225出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1753944717711379
关键词
metabolic syndrome; nutraceuticals; cardiovascular disease; hypertension; obesity; insulin resistance; atherogenic dyslipidemia
Metabolic syndrome (MetS) represents a cluster of metabolic abnormalities that include hypertension, central obesity, insulin resistance, and atherogenic dyslipidemia, and is strongly associated with an increased risk for developing diabetes and atherosclerotic and nonatherosclerotic cardiovascular disease (CVD). The pathogenesis of MetS involves both genetic and acquired factors that contribute to the final pathway of inflammation that leads to CVD. MetS has gained significant importance recently due to the exponential increase in obesity worldwide. Early diagnosis is important in order to employ lifestyle and risk factor modification. Here, we review the epidemiology and pathogenesis of MetS, the role of inflammation in MetS, and summarize existing natural therapies for MetS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据